Lamivudine treatment of chronic hepatitis B Factors and Countermeasures.docVIP

Lamivudine treatment of chronic hepatitis B Factors and Countermeasures.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Lamivudine treatment of chronic hepatitis B Factors and Countermeasures

 PAGE \* MERGEFORMAT 7 Lamivudine treatment of chronic hepatitis B Factors and Countermeasures [Abstract] In order to improve the chronic hepatitis B patients on lamivudine therapy compliance, and thus improve the therapeutic effect. Our hospital in May 2005 ~ March 2007 lamivudine in the treatment of poor compliance in 43 patients with analysis of factors affecting the summary of the factors that affect the formulation of corresponding proposals to enhance the treatment of patients compliance. The results showed that lack of knowledge, life is not the law, lack of social support, self-evaluation is a poor efficacy in patients with chronic hepatitis B lamivudine in the treatment compliance of the main factors for the above factors, to develop and implement appropriate countermeasures to improve patient treatment compliance. [Keywords:] chronic hepatitis B; Lamivudine; treatment; influencing factors; Countermeasures Chronic hepatitis B is a serious harm to human lives and health, infectious diseases, it is not only to patients and their families has brought enormous economic burden and mental stress, but also increase the health of people infected with hepatitis B virus. At present the view that anti-viral therapy is the treatment of chronic hepatitis B key. Lamivudine is an oral antiviral drugs, because of its oral convenient, less pain for many patients to accept. But its course a long, costly, and the medication may appear during the repeated condition, the virus mutate and so on, so that the treatment compliance of patients be affected, thereby affecting therapeutic effect. Therefore, we in May 2005 ~ March 2007 in our hospital receiving lamivudine treatment for 138 patients with chronic hepatitis B in the study to improve treatment compliance, poor treatment compliance of 43 cases of influencing factors and countermeasures for the analysis, summarized as follows: A lack of knowledge Lack of knowledge of hepatitis B patients with 18 cases, accounting

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档